BPC 157: Experimental Peptide Creates Risk for Athletes Compounded "semaglutide" is not FDA approved semaglutide.com BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Is BPC 157 Legal? Understanding Its Status and Implications